Our golden biomarker in the panel is the central mediator of DNA repair that directly influences Pt-chemotherapy outcomes. It is an ideal testcandidate that can be used throughout the journey of the patient from diagnosis to recovery. We will show soon that our test panel is predictive and prognostic.
October 3rd, 2025: Testing will begin this month when we receive blood samples from a women's hospital. Contact us for more details.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.